These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10325933)

  • 41. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of weddellite formation: chondroitin sulfates and citrate determine weddellite formation in vitro.
    Kim KM
    Scanning Microsc; 1996; 10(2):445-55; discussion 455-7. PubMed ID: 9813623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate].
    Morimoto S
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 46. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Calcium oxalate activity products and discriminant analysis of urinary parameters as basis for a calcium oxalate screening program (author's transl)].
    Brundig P; Berg W; Naumann J; Hoppe H; Cumme GA; Achilles W; Schneider HJ
    Urologe A; 1980 Jan; 19(1):54-6. PubMed ID: 7355530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
    Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduced crystallization inhibition by urine from women with nephrolithiasis.
    Asplin JR; Parks JH; Nakagawa Y; Coe FL
    Kidney Int; 2002 May; 61(5):1821-9. PubMed ID: 11967033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnesium hydrogen carbonate natural mineral water enriched with K(+)-citrate and vitamin B6 improves urinary abnormalities in patients with calcium oxalate nephrolithiasis.
    Bren A; Kmetec A; Kveder R; Kaplan-Pavlovcic S
    Urol Int; 1998; 60(2):105-7. PubMed ID: 9563149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men.
    Kok DJ; Iestra JA; Doorenbos CJ; Papapoulos SE
    J Clin Endocrinol Metab; 1990 Oct; 71(4):861-7. PubMed ID: 2401715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A thermodynamic equilibrium model for calcium salt urolithiasis: clinical application.
    Ashby R; Györy AZ
    Exp Nephrol; 1997; 5(3):246-52. PubMed ID: 9208285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A simple method for quantitating the propensity for calcium oxalate crystallization in urine.
    Wabner CL; Pak CY
    J Lithotr Stone Dis; 1991 Jul; 3(3):255-9. PubMed ID: 11536933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth retardation of weddellite (calcium oxalate dihydrate) by sodium copper chlorophyllin.
    Tawashi R; Cousineau M
    Invest Urol; 1980 Sep; 18(2):86-9. PubMed ID: 7437122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A contribution to the formation mechanism of calcium oxalate urinary calculi. I. Stabilising urinary constituents in the formation of weddellite.
    Hesse A; Berg W; Schneider HJ; Hienzsch E
    Urol Res; 1976 Nov; 4(3):125-8. PubMed ID: 1014173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of lithogenic urinary parameters with a low dose potassium citrate treatment.
    Grases F; Conte A; March JG; García-Ferragut L
    Int Urol Nephrol; 1998; 30(1):1-8. PubMed ID: 9569103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.